By using the immunogenetic dataset from MSKCC group 39, we also noticed patients with mutations in CDH6 or other core CDH genes showed more γδT cell recruitments in melanoma lesions with more activated CD4+ memory T cells and higher cytolytic scores (Figure S12). The gene discussed is CDH6; the disease is melanoma.